DRUGS MADE IN AMERICA ACQUISITION II CORP.: cashflow_operating
| Value | {"amount": -10044, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | DRUGS MADE IN AMERICA ACQUISITION II CORP. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c40acfe1-6033-4af3-9e28-7b5120334aa8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-056651Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0002040475/cashflow-operating/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c40acfe1-6033-4af3-9e28-7b5120334aa8
History
- no predecessors — first report